Chirality‐Encoded Biomaterials Regulate Local and Systemic Immune Responses in Transplantation
Advanced Materials · 2026-09 · 38 (52)
DOI: 10.1002/adma.74185 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 25.07.2026. Verfasst von Holly C Lewis und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Duke University, Durham, North Carolina, USA. Hauptthemen laut MEDLINE: Skin Transplantation, Biocompatible Materials. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Duke Medical Sciences Training Program, NIH HHS, NIAID NIH HHS.
Abstract (Originalsprache)
Biomaterial‐based immune modulation offers an opportunity to achieve localized graft acceptance without systemic immunosuppression. Here, we demonstrate that molecular chirality within microporous annealed particle (MAP) hydrogels governs innate and adaptive immune responses in skin transplantation and is associated with modulation of alloimmune outcomes. By engineering injectable MAP scaffolds composed of microgels crosslinked with L‐ or D‐peptides, we show that chirality directs early antigen‐presenting cell (APC) activation and trafficking in draining lymph nodes, leading to distinct T cell polarization profiles. A mixed‐chirality formulation (R‐MAP) composed of L‐ and D‐microgels is associated with reduced APC co‐stimulatory signaling (MHC II, CD80, CD86) and preserves graft architecture and tissue integration in syngeneic transplants. In fully allogeneic skin grafts, local mixed‐chirality MAP implantation is associated with reduced donor‐specific antibody (DSA) formation and attenuated antimaterial and antidonor IgG responses, achieving sustained attenuation of humoral alloimmunity within the experimental conditions studied. These findings establish stereochemical control of biomaterial composition as a design principle for modulating APC‐T‐B cell crosstalk, linking local material cues to systemic immune outcomes. Mixed‐chirality MAP scaffolds thus provide a versatile platform for spatially confined, chirality‐guided immunomodulation, with implications for transplantation, regenerative medicine, and biomaterial‐driven tolerance strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery, Duke University, Durham, North Carolina, USA.
- Department of Biomedical Engineering, Pratt School of Engineering, Durham, North Carolina, USA.
- Center For Biomolecular and Tissue Engineering, Duke University, Durham, North Carolina, USA.
Förderung
- Duke Medical Sciences Training Program
- NIH HHS
- NIAID NIH HHS
- NIGMS NIH HHS
- National Institutes of Health
Zitieren
APA
Lewis, H. C., Jeffs, S., Espinoza, A., Goud, R., Suarez-Arnedo, A., Owusu-Antwi, S., Alvarado, P. C., & Segura, T. (2026). Chirality‐Encoded Biomaterials Regulate Local and Systemic Immune Responses in Transplantation. Advanced Materials, 38(52). https://doi.org/10.1002/adma.74185
Vancouver
Lewis HC, Jeffs S, Espinoza A, Goud R, Suarez-Arnedo A, Owusu-Antwi S, et al. Chirality‐Encoded Biomaterials Regulate Local and Systemic Immune Responses in Transplantation. Advanced Materials. 2026;38(52). doi:10.1002/adma.74185
BibTeX
@article{Lewis2026,
author = {Lewis, Holly C and Jeffs, Sydney and Espinoza, April and Goud, Reshma and Suarez-Arnedo, Alejandra and Owusu-Antwi, Samantha and Alvarado, Pablo Cordero and Segura, Tatiana},
title = {Chirality‐Encoded Biomaterials Regulate Local and Systemic Immune Responses in Transplantation},
journal = {Advanced Materials},
year = {2026},
volume = {38},
number = {52},
doi = {10.1002/adma.74185}
}
EUVIMED